Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,852 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood.
Kücüksezer UC, Palomares O, Rückert B, Jartti T, Puhakka T, Nandy A, Gemicioğlu B, Fahrner HB, Jung A, Deniz G, Akdis CA, Akdis M. Kücüksezer UC, et al. Among authors: jung a. J Allergy Clin Immunol. 2013 Mar;131(3):875-85. doi: 10.1016/j.jaci.2012.10.051. Epub 2012 Dec 23. J Allergy Clin Immunol. 2013. PMID: 23265862
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance.
Palomares O, Rückert B, Jartti T, Kücüksezer UC, Puhakka T, Gomez E, Fahrner HB, Speiser A, Jung A, Kwok WW, Kalogjera L, Akdis M, Akdis CA. Palomares O, et al. Among authors: jung a. J Allergy Clin Immunol. 2012 Feb;129(2):510-20, 520.e1-9. doi: 10.1016/j.jaci.2011.09.031. Epub 2011 Nov 3. J Allergy Clin Immunol. 2012. PMID: 22051696
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
Worm M, Alexiou A, Bauer A, Treudler R, Wurpts G, Dickel H, Buhl T, Müller S, Jung A, Brehler R, Fluhr J, Klimek L, Mülleneisen N, Pfützner W, Raap U, Roeseler S, Schuh S, Timmermann H, Heine G, Wedi B, Brockow K. Worm M, et al. Among authors: jung a. Allergy. 2022 Nov;77(11):3426-3434. doi: 10.1111/all.15414. Epub 2022 Jul 4. Allergy. 2022. PMID: 35722723 Free PMC article.
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P. Maurer M, et al. Among authors: jung a. J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2. J Allergy Clin Immunol. 2011. PMID: 21636116 Clinical Trial.
A Pilot Randomized Controlled Trial of Families Addressing Cancer Together for Parents With Cancer: Feasibility, Acceptability, and Preliminary Effects.
Nakamura ZM, Deal AM, Yopp JM, Wardell AC, Manning M, Pak P, Cassidy A, Hanson LC, Jung A, Song MK, Valle CG, Walker C, Won H, Park EM, Rosenstein DL. Nakamura ZM, et al. Among authors: jung a. Psychooncology. 2025 Jan;34(1):e70072. doi: 10.1002/pon.70072. Psychooncology. 2025. PMID: 39763133 Clinical Trial.
1,852 results